|
ATCC
skov 3 Skov 3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/SK-OV-3/pmc04914309-86-0-1 Average 99 stars, based on 1 article reviews
skov 3 - by Bioz Stars,
2026-09
99/100 stars
|
Buy from Supplier |
|
CLS Cell Lines Service GmbH
sk ov Sk Ov, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/SK-OV-3+Cells/pm36970146-503-110-122 Average 94 stars, based on 1 article reviews
sk ov - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
ATCC
human ovarian serous adenocarcinoma cell lines skov3 ![]() Human Ovarian Serous Adenocarcinoma Cell Lines Skov3, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/SK-OV-3%3B+Ovarian+Adenocarcinoma%3B+Human/pm37759323-40-0-7 Average 96 stars, based on 1 article reviews
human ovarian serous adenocarcinoma cell lines skov3 - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
|
Chem Impex International
dexamethasone dex ![]() Dexamethasone Dex, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/Dexamethasone/pm37158305-50-29-50 Average 95 stars, based on 1 article reviews
dexamethasone dex - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
Genecopoeia
sk ov 3 cells ![]() Sk Ov 3 Cells, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/Human+cell+line+SK-OV-3+stably+expressing+Cas9%2C+randomly+inserted%2C+single+clone/pm29563539-274-26-34 Average 95 stars, based on 1 article reviews
sk ov 3 cells - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
sk ov 3 ![]() Sk Ov 3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/SK-OV-3+Whole+Cell+Lysate/pm21447598-115-64-32 Average 86 stars, based on 1 article reviews
sk ov 3 - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
|
CEM Corporation
sk-ov-3 ![]() Sk Ov 3, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/sk+ov+3/pm23537165-157-25-24 Average 90 stars, based on 1 article reviews
sk-ov-3 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
JCRB Cell Bank
luciferase expressing sk-ov-3-luc cells ![]() Luciferase Expressing Sk Ov 3 Luc Cells, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/luciferase+expressing+sk+ov+3+luc+cells/pmc07036012-127-0-7 Average 90 stars, based on 1 article reviews
luciferase expressing sk-ov-3-luc cells - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Protia Llc
cellvue maroon-labeled sk-ov-3 cells ![]() Cellvue Maroon Labeled Sk Ov 3 Cells, supplied by Protia Llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/cellvue+maroon+labeled+sk+ov+3+cells/us12060424-1100-25-50 Average 90 stars, based on 1 article reviews
cellvue maroon-labeled sk-ov-3 cells - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
JCRB Cell Bank
cell line sk-ov-3 ![]() Cell Line Sk Ov 3, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/cell+line+sk+ov+3/pmc07507800-52-1-27 Average 90 stars, based on 1 article reviews
cell line sk-ov-3 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
China Center for Type Culture Collection
eoc cell lines sk-ov-3 ![]() Eoc Cell Lines Sk Ov 3, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/eoc+cell+lines+sk+ov+3/pmc08340904-34-1-12 Average 90 stars, based on 1 article reviews
eoc cell lines sk-ov-3 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
GemPharmatech Co Ltd
sk-ov-3/yes1 y537f cells ![]() Sk Ov 3/Yes1 Y537f Cells, supplied by GemPharmatech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/sk+ov+3+yes1+y537f+cells/pmc07494777-50-37-50 Average 90 stars, based on 1 article reviews
sk-ov-3/yes1 y537f cells - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cell & bioscience
Article Title: MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC.
doi: 10.1186/s13578-023-01117-0
Figure Lengend Snippet: Fig. 3 MRE11:p.K464R mutation leads to Olaparib resistance in ovarian cancer cells. (A-B) The stable cell lines of SKOV3 (A) and A2780-MRE11WT/MRE11K464R (B) were constructed expressing MRE11WT and MRE11K464R protein and detected the MRE11 protein expression with West ern blot. (C-D) SKOV3 (C) and A2780 (D) MRE11WT /MRE11K464R cells were treated for 96 h with indicated dose of Olaparib and viability assessed by CCK8. (E-F) Representative pictures of colony formation assay in SKOV3 (E) and A2780 (F) MRE11WT /MRE11K464R cells treated with or without Olaparib for 10 days are in left. Relative colony formation rates of cell are presented as percent relative to DMSO (right). (G-H) SKOV3 (G) and A2780 (H) MRE11WT/MRE11K464R cells were treated with or without Olaparib for 48 h and then stained for γH2AX, MRE11, and DAPI (left), and quantified the γH2AX foci per cell (right). Scale bar, 25 μm. (I-J) SKOV3 (I) and A2780 (J) MRE11WT/ MRE11K464R cells were treated with or without Olaparib for 48 h and subjected to Comet analysis. DNA damage is quantified as percent DNA in tails. Each group represents at least 100 cells counted. Data are presented as mean values ± SEM from three independent experiments. ***p < 0.001, ****p < 0.0001, ns, not significant, as determined by the unpaired two-tailed Student’s t-test
Article Snippet:
Techniques: Mutagenesis, Stable Transfection, Construct, Expressing, Colony Assay, Staining, Two Tailed Test
Journal: Cell & bioscience
Article Title: MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC.
doi: 10.1186/s13578-023-01117-0
Figure Lengend Snippet: Fig. 4 Interactions of MRE11:p.K464R with RAD50/RPS3. (A) Schematic diagram of IP-MS detection. (B) The directly-interacting proteins of MRE11 were screened in the String database according to the IP-MS data. (C-D) SKOV3- MRE11WT/MRE11K464R cells were treated with or without Olaparib for 24 h. The cells were then lysed and immunoprecipitation with MRE11 antibody (C) and the relative gray scale density of RAD50(up) and RPS3 (down) to MRE11 are presented in D.(E-F) SKOV3- MRE11WT/MRE11K464R cells were treated with Olaparib or DMSO. The cells were then lysed and immunoprecipitation with RPS3 antibody (E) and the relative gray scale density of RAD50 (up) and MRE11 (down) to MRE11 are presented in F. (G-H) Detection of MRE11-RAD50 (G) and MRE11-RPS3(H) interaction was carried out by PLA labeling in SKOV3 MRE11WT/MRE11K464R cells treated with or without Olaparib for 24 h. Rep resentative images are shown. Scale bars, 5 μm. The scatterplot displays quantification of the PLA signals per nucleus from at least 100 cells from three independent experiments. Data are mean ± SEM. (I-J) ER-AsiSI Hela cells were transfected with empty vector or MRE11WT or MRE11K464R, and then treated with 4-OHT to induce DSBs. RAD50 (I) and RPS3 (J) accumulation at DNA damage sites generated by AsiSI was detected by ChIP qPCR. Data are presented as mean values ± SEM from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns, not significant, as determined by the unpaired two-tailed Student’s t-test
Article Snippet:
Techniques: Protein-Protein interactions, Immunoprecipitation, Labeling, Transfection, Plasmid Preparation, Generated, ChIP-qPCR, Two Tailed Test
Journal: Cell & bioscience
Article Title: MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC.
doi: 10.1186/s13578-023-01117-0
Figure Lengend Snippet: Fig. 5 Effects of MRE11_K464R mutation on NHEJ pathway. (A) Expression of NHEJ key proteins in SKOV3 MRE11WT /MRE11K464R cells after treated with Olaparib for 48 h, detected by Western Blot with indicated antibodies. (B) MRE11WT or MRE11K464R virus were infected into EJ5-Hela cells for 24 h. Then, the cells were transfected with an I-SceI expression plasmid for 48 h. NHEJ efficiency were determined by FACS. (C) ER-AsiSI Hela cells were infected with MRE11WT or MRE11K464R virus, and then treated with 4-OHT to induce DSBs. Ku70 accumulation at DNA damage sites generated by AsiSI was detect ed by ChIP qPCR. (D) A2780 MRE11WT /MRE11K464R cells after treated with Olaparib for 48 h. The chromatin fractions and the soluble nuclear fractions were analyzed with indicated antibodies by Western Blot. (E-F) A2780 MRE11WT /MRE11K464R cells were treated with or with Olaparib for 48 h, and co-stained with Ku70 (green) and γH2AX (red) antibodies. E The representative images of immunofluorescence are presented, F quantification of Ku70 and γH2AX co-localization ratio per cell. Each group represents at least 100 cells counted. Scale bar, 10 μm. (G) MRE11_K464R with or without siNC/siRAD50/siRPS3 were infected into EJ5-Hela cells for 24 h. Then, the cells were transfected with an I-SceI expression plasmid for 48 h. NHEJ efficiency were determined by FACS. (H) MRE11_K464R with or without siNC/siRAD50/siRPS3 were infected into ER-AsiSI Hela cells and then treated with 4-OHT to induce DSBs. Ku70 accumulation at DNA damage sites generated by AsiSI was detected by ChIP qPCR. (I) SKOV3 (left) and A2780 (right) MRE11K464R cells were treated for 96 h with indicated doses of Olaparib or SCR7 (up) / AZD7648 (down) alone or combined for 96 h and viability assessed. Data are presented as mean values ± SEM from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns, not significant, as determined by the unpaired two-tailed Student’s t-test
Article Snippet:
Techniques: Mutagenesis, Expressing, Western Blot, Virus, Infection, Transfection, Plasmid Preparation, Generated, ChIP-qPCR, Staining, Immunofluorescence, Two Tailed Test
Journal: Cell & bioscience
Article Title: MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC.
doi: 10.1186/s13578-023-01117-0
Figure Lengend Snippet: Fig. 6 RPS3/RAD50 knockdown sensitizes K464R mutant cells to Olaparib. (A-B) SKOV3 (A) and A2780 (B) MRE11K464R cells were transfected with siRAD50 or siRPS3 alone or combine for 24 h and then treated for 96 h with indicated doses of Olaparib and viability was measured by CCK8. The expres sion of scramble siRNA (siNC) was used as control. (C-D) Cells were transfected with siRAD50 or siRPS3 alone or combine for 24 h and then treated with or without Olaparib for 10 days. The expression of siNC was used as control. Representative pictures of clonogenic assay in A2780 MRE11K464R cells (C). The mean clones of ROI are presented (D). (E-F) SKOV3 (E) and A2780 (F) MRE11K464R cells were transfected with siRAD50 or siRPS3 alone or combine for 24 h and then treated for 48 h and then subjected to Comet analysis. DNA damage is quantified as percent DNA in tails. The expression of siNC was used as control. Each group represents at least 150 cells counted. (G-H) SKOV3 (G) and A2780(H) MRE11K464R cells were transfected with siRAD50 or siRPS3 alone or combine for 24 h and then treated with or without Olaparib for 48 h and then stained for γH2AX (green) and DAPI (blue), and γH2AX foci-positive cells were quantified (below). Each group represents at least 150 cells counted. Scale bar, 20 μm. Data are presented as mean values ± SEM from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns, not significant, as determined by the unpaired two-tailed Student’s t-test
Article Snippet:
Techniques: Knockdown, Mutagenesis, Transfection, Control, Expressing, Clonogenic Assay, Clone Assay, Staining, Two Tailed Test
Journal: PeerJ
Article Title: Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer
doi: 10.7717/peerj.11591
Figure Lengend Snippet: (A) MTT cell viability assays were performed to determine the IC50s of aspirin in A2780, Caov-3 and SK-OV-3 cells over a 48-h culture period. (B) Cell proliferation was detected using EdU cell proliferation assays (bar, 50 µm) after treatment with different concentrations of aspirin (0 µM, 100 µM, and 1,000 µM) in A2780 cells. (C) Quantitative assay of proliferation rate in A2780, Caov-3 and SK-OV-3 cells. (D) Colony formation assays were conducted after cells were cultured with different concentrations of aspirin (0 µM, 25 µM, 100 µM, 500 µM, 1,000 µM, and 25 µM) for 14 days in A2780 cells. (E) Quantitative assay of colony counts in A2780, Caov-3 and SK-OV-3 cells. (F) Cells were treated with different concentrations of aspirin (0 µM, 100 µM, and 1,000 µM) for 48 h in A2780 cells, stained with the Annexin V-FITC/PI staining kit, and analyzed using flow cytometry. (G) Quantitative assay of apoptosis rate in A2780, Caov-3 and SK-OV-3 cells. Data are presented as the mean ± SD values. * p < 0.05.
Article Snippet: The
Techniques: Cell Culture, Staining, Flow Cytometry
Journal: PeerJ
Article Title: Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer
doi: 10.7717/peerj.11591
Figure Lengend Snippet: (A) The cell proliferation rate was determined using EdU cell proliferation assays after the incubation of A2780 cells with CDDP (20 µM) alone or in combination with aspirin (100 µM) (CDDP + aspirin) for 48 h (bar, 50 µm). (B) Quantitative assay of proliferation rate in A2780 and SK-OV-3 cells. (C) Colony formation assays were conducted to observe the growth of A2780 cells after an incubation with CDDP (5 µM) alone or with aspirin (25 µM) for 48 h. (D) Quantitative assay of colony counts in A2780 and SK-OV-3 cells. (E) The percentage of apoptotic cells was determined using flow cytometry after the treatment of A2780 cells with CDDP (20 µM) alone or with aspirin (100 µM). (F) Quantitative assay of apoptosis rate in A2780 and SK-OV-3 cells. Data are presented as the mean ± SD values. * p < 0.05.
Article Snippet: The
Techniques: Incubation, Flow Cytometry
Journal: PeerJ
Article Title: Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer
doi: 10.7717/peerj.11591
Figure Lengend Snippet: Orthotopic xenograft mouse models of EOC were established with A2780-Luciferase cells using surgical orthotopic implantation to observe the effects of aspirin in vivo . Aspirin was initially administered on day 9 at a dose of 20 mg/kg by gavage and then every other day thereafter, while CDDP administration was initiated at a dose of 3 mg/kg by intraperitoneal injection on day 17 and then every fourth day thereafter. Tumor growth was observed with an IVIS Lumina II beginning on day 8 and then once per week thereafter to obtain in vivo bioluminescence images. (A) The tumor signals in all mice (control group, CDDP group, and CDDP + aspirin group) at every time point are displayed. (B) The tumor growth curve for each group based on the tumor signals is shown. (C) All mice were euthanized via overdose isoflurane inhalation on day 36 and necropsied for the measurement of tumor diameters with Vernier calipers. (D) Quantitative assay of tumor volume in mice. (E) The expression levels of cleaved caspase 3, caspase 3 and Ki67 in tumor tissues harvested from mice bearing orthotopic EOC xenografts (control group, CDDP group, and CDDP + aspirin group) were assessed using IHC. (F) Quantitative assay for the IHC data of cleaved caspase 3, caspase 3 and Ki67. Data are presented as the mean ± SD values. * p < 0.05.
Article Snippet: The
Techniques: Luciferase, In Vivo, Injection, Control, Expressing